Wunderlich Boosts Nutrisystem Inc. (NTRI) Price Target to $37.00
Nutrisystem Inc. (NASDAQ:NTRI) had its price target lifted by Wunderlich from $31.00 to $37.00 in a research report issued to clients and investors on Wednesday. The firm presently has a “buy” rating on the stock. Wunderlich’s price target would indicate a potential upside of 20.52% from the stock’s previous close.
Several other research firms have also recently weighed in on NTRI. Zacks Investment Research cut shares of Nutrisystem from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 7th. B. Riley reissued a “buy” rating and issued a $41.00 price target on shares of Nutrisystem in a research report on Wednesday, July 27th. Barrington Research reissued an “outperform” rating on shares of Nutrisystem in a research report on Sunday, July 31st. Finally, Citigroup Inc. increased their price target on shares of Nutrisystem from $31.00 to $36.00 and gave the stock a “neutral” rating in a research report on Tuesday, September 13th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $33.67.
Nutrisystem (NASDAQ:NTRI) opened at 30.70 on Wednesday. The stock’s 50 day moving average price is $29.21 and its 200 day moving average price is $26.54. Nutrisystem has a 12 month low of $17.25 and a 12 month high of $31.05. The firm has a market capitalization of $898.71 million, a P/E ratio of 30.37 and a beta of 0.76.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/19/wunderlich-boosts-nutrisystem-inc-ntri-price-target-to-37-00.html
Nutrisystem (NASDAQ:NTRI) last released its earnings results on Wednesday, July 27th. The company reported $0.54 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.50 by $0.04. Nutrisystem had a net margin of 5.87% and a return on equity of 45.65%. The business earned $149.80 million during the quarter, compared to analysts’ expectations of $148.77 million. During the same quarter last year, the company earned $0.41 earnings per share. The firm’s revenue was up 15.0% on a year-over-year basis. On average, analysts forecast that Nutrisystem will post $1.11 earnings per share for the current year.
In other news, insider Dawn M. Zier sold 25,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 20th. The shares were sold at an average price of $28.62, for a total transaction of $715,500.00. Following the completion of the sale, the insider now owns 247,171 shares of the company’s stock, valued at $7,074,034.02. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Brian Tierney sold 7,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 16th. The stock was sold at an average price of $29.25, for a total transaction of $204,750.00. Following the sale, the director now directly owns 40,620 shares of the company’s stock, valued at approximately $1,188,135. The disclosure for this sale can be found here. Insiders own 2.90% of the company’s stock.
Several hedge funds have recently bought and sold shares of NTRI. Emerald Advisers Inc. PA raised its stake in Nutrisystem by 150.8% in the second quarter. Emerald Advisers Inc. PA now owns 942,255 shares of the company’s stock valued at $23,896,000 after buying an additional 566,608 shares during the last quarter. Renaissance Technologies LLC boosted its stake in Nutrisystem by 2.1% in the first quarter. Renaissance Technologies LLC now owns 2,777,800 shares of the company’s stock valued at $57,973,000 after buying an additional 56,800 shares during the period. Emerald Mutual Fund Advisers Trust bought a new stake in Nutrisystem during the second quarter valued at approximately $12,916,000. Scholtz & Company LLC bought a new stake in Nutrisystem during the first quarter valued at approximately $1,548,000. Finally, Integre Asset Management LLC bought a new stake in Nutrisystem during the first quarter valued at approximately $550,000. 93.71% of the stock is owned by institutional investors.
Nutrisystem, Inc (Nutrisystem) is a provider of weight management products and services, including nutritionally balanced weight loss programs, multi-day kits available at retail locations and digital tools to support weight loss. The Company’s program customers purchase monthly food packages containing four-week meal plan consisting supply of breakfasts, lunches, dinners and snacks and flex meal plan recipes, which they supplement with fresh fruits, vegetables and dairy.
Receive News & Ratings for Nutrisystem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrisystem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.